Nicholas Company’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.9M | Sell |
182,687
-182
| -0.1% | -$9.83K | 0.24% | 88 |
|
|
2026
Q1 | $9.56M | Sell |
182,869
-207,925
| -53% | -$12.5M | 0.19% | 106 |
|
|
2025
Q4 | $23M | Buy |
390,794
+23,785
| +6% | +$1.45M | 0.4% | 61 |
|
|
2025
Q3 | $20.4M | Buy |
367,009
+108,350
| +42% | +$5.8M | 0.35% | 73 |
|
|
2025
Q2 | $13.3M | Sell |
258,659
-15
| -0% | -$754 | 0.22% | 100 |
|
|
2025
Q1 | $15.2M | Hold |
258,674
| – | – | 0.26% | 97 |
|
|
2024
Q4 | $18.6M | Sell |
258,674
-325
| -0.1% | -$23.9K | 0.3% | 85 |
|
|
2024
Q3 | $20.7M | Sell |
258,999
-5,830
| -2% | -$438K | 0.34% | 81 |
|
|
2024
Q2 | $19M | Hold |
264,829
| – | – | 0.32% | 87 |
|
|
2024
Q1 | $18.6M | Buy |
264,829
+31,970
| +14% | +$2.29M | 0.31% | 95 |
|
|
2023
Q4 | $18M | Buy |
232,859
+64,250
| +38% | +$4.23M | 0.32% | 89 |
|
|
2023
Q3 | $11.5M | Buy |
168,609
+142,510
| +546% | +$11.3M | 0.23% | 103 |
|
|
2023
Q2 | $2.13M | Buy |
+26,099
| New | +$2.1M | 0.04% | 212 |
|
|
2021
Q3 | – | Sell |
-45,900
| Closed | -$5.17M | – | 238 |
|
|
2021
Q2 | $5.17M | Sell |
45,900
-63,560
| -58% | -$6.69M | 0.09% | 213 |
|
|
2021
Q1 | $10.5M | Sell |
109,460
-26,380
| -19% | -$2.41M | 0.2% | 128 |
|
|
2020
Q4 | $10.8M | Buy |
135,840
+20
| +0% | +$1.45K | 0.2% | 125 |
|
|
2020
Q3 | $8.41M | Hold |
135,820
| – | – | 0.18% | 133 |
|
|
2020
Q2 | $8.97M | Sell |
135,820
-4,440
| -3% | -$266K | 0.21% | 120 |
|
|
2020
Q1 | $6.65M | Hold |
140,260
| – | – | 0.19% | 124 |
|
|
2019
Q4 | $7.7M | Sell |
140,260
-20
| -0% | -$1.05K | 0.16% | 141 |
|
|
2019
Q3 | $6.86M | Hold |
140,280
| – | – | 0.15% | 149 |
|
|
2019
Q2 | $7.31M | Sell |
140,280
-120
| -0.1% | -$6.05K | 0.16% | 138 |
|
|
2019
Q1 | $6.97M | Sell |
140,400
-300
| -0.2% | -$13.5K | 0.17% | 138 |
|
|
2018
Q4 | $5.09M | Sell |
140,700
-2,080
| -1% | -$86.9K | 0.13% | 173 |
|
|
2018
Q3 | $7.29M | Sell |
142,780
-6,140
| -4% | -$272K | 0.16% | 144 |
|
|
2018
Q2 | $5.51M | Sell |
148,920
-10,000
| -6% | -$382K | 0.13% | 168 |
|
|
2018
Q1 | $6M | Sell |
158,920
-380
| -0.2% | -$13.4K | 0.14% | 145 |
|
|
2017
Q4 | $5.16M | Hold |
159,300
| – | – | 0.11% | 168 |
|
|
2017
Q3 | $4.81M | Sell |
159,300
-760
| -0.5% | -$22.6K | 0.11% | 177 |
|
|
2017
Q2 | $4.7M | Hold |
160,060
| – | – | 0.1% | 172 |
|
|
2017
Q1 | $4.07M | Buy |
160,060
+8,000
| +5% | +$207K | 0.09% | 181 |
|
|
2016
Q4 | $3.91M | Buy |
152,060
+1,500
| +1% | +$39.4K | 0.09% | 177 |
|
|
2016
Q3 | $4.12M | Hold |
150,560
| – | – | 0.09% | 163 |
|
|
2016
Q2 | $4.24M | Hold |
150,560
| – | – | 0.09% | 146 |
|
|
2016
Q1 | $3.56M | Buy |
150,560
+1,620
| +1% | +$35.7K | 0.07% | 158 |
|
|
2015
Q4 | $3.35M | Buy |
148,940
+68,500
| +85% | +$1.56M | 0.06% | 170 |
|
|
2015
Q3 | $1.86M | Sell |
80,440
-260
| -0.3% | -$6.52K | 0.04% | 193 |
|
|
2015
Q2 | $1.99M | Hold |
80,700
| – | – | 0.03% | 198 |
|
|
2015
Q1 | $2.02M | Hold |
80,700
| – | – | 0.04% | 200 |
|
|
2014
Q4 | $1.86M | Hold |
80,700
| – | – | 0.04% | 208 |
|
|
2014
Q3 | $1.89M | Hold |
80,700
| – | – | 0.04% | 212 |
|
|
2014
Q2 | $1.87M | Sell |
80,700
-100
| -0.1% | -$2.21K | 0.04% | 215 |
|
|
2014
Q1 | $1.72M | Sell |
80,800
-39,540
| -33% | -$890K | 0.04% | 221 |
|
|
2013
Q4 | $2.85M | Hold |
120,340
| – | – | 0.07% | 212 |
|
|
2013
Q3 | $2.41M | Buy |
+120,340
| New | +$2.28M | 0.06% | 216 |
|
Other funds holding TECH
Nicholas Company's TECH Position: Q2 2026 in Review
Nicholas Company reduced its Bio-Techne (TECH) stake by 0.1% in Q2 2026, selling an estimated $9.83K and leaving 182,687 shares worth $12.9M. The position accounts for 0.24% of the portfolio, ranked #88.
Nicholas Company first reported a position in TECH in Q3 2013 and has held it in 45 quarters since. The position peaked at $23M in Q4 2025. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- Nicholas Company held 182,687 shares of Bio-Techne worth $12.9M as of Q2 2026.
- Nicholas Company sold 182 Bio-Techne shares in Q2 2026, an estimated $9.83K.
- Bio-Techne made up 0.24% of Nicholas Company's portfolio in Q2 2026, its #88 holding.
- Nicholas Company first reported a position in Bio-Techne in Q3 2013 and has held it in 45 quarters since.
- Nicholas Company's Bio-Techne position peaked at $23M in Q4 2025.
- 597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on Nicholas Company's 13F filing for Q2 2026, filed 5 Aug 2026.